406 related articles for article (PubMed ID: 17048488)
21. Evaluation of the physicochemical properties and the biocompatibility of polyethylene glycol-conjugated gold nanoparticles: A formulation strategy for siRNA delivery.
Rahme K; Guo J; Holmes JD; O'Driscoll CM
Colloids Surf B Biointerfaces; 2015 Nov; 135():604-612. PubMed ID: 26322474
[TBL] [Abstract][Full Text] [Related]
22. Biodegradable polymeric nanocarriers for pulmonary drug delivery.
Rytting E; Nguyen J; Wang X; Kissel T
Expert Opin Drug Deliv; 2008 Jun; 5(6):629-39. PubMed ID: 18532919
[TBL] [Abstract][Full Text] [Related]
23. Biodegradable nanoparticles for drug and gene delivery to cells and tissue.
Panyam J; Labhasetwar V
Adv Drug Deliv Rev; 2003 Feb; 55(3):329-47. PubMed ID: 12628320
[TBL] [Abstract][Full Text] [Related]
24. Functionalized STAT1 siRNA nanoparticles regress rheumatoid arthritis in a mouse model.
Scheinman RI; Trivedi R; Vermillion S; Kompella UB
Nanomedicine (Lond); 2011 Dec; 6(10):1669-82. PubMed ID: 22087799
[TBL] [Abstract][Full Text] [Related]
25. The use of anti-COX2 siRNA coated onto PLGA nanoparticles loading dexamethasone in the treatment of rheumatoid arthritis.
Park JS; Yang HN; Jeon SY; Woo DG; Kim MS; Park KH
Biomaterials; 2012 Nov; 33(33):8600-12. PubMed ID: 22910222
[TBL] [Abstract][Full Text] [Related]
26. Translocator protein ligand-PLGA conjugated nanoparticles for 5-fluorouracil delivery to glioma cancer cells.
Laquintana V; Denora N; Lopalco A; Lopedota A; Cutrignelli A; Lasorsa FM; Agostino G; Franco M
Mol Pharm; 2014 Mar; 11(3):859-71. PubMed ID: 24410438
[TBL] [Abstract][Full Text] [Related]
27. Spray drying of siRNA-containing PLGA nanoparticles intended for inhalation.
Jensen DM; Cun D; Maltesen MJ; Frokjaer S; Nielsen HM; Foged C
J Control Release; 2010 Feb; 142(1):138-45. PubMed ID: 19840823
[TBL] [Abstract][Full Text] [Related]
28. Preparation of polyethyleneimine incorporated poly(D,L-lactide-co-glycolide) nanoparticles by spontaneous emulsion diffusion method for small interfering RNA delivery.
Katas H; Cevher E; Alpar HO
Int J Pharm; 2009 Mar; 369(1-2):144-54. PubMed ID: 19010405
[TBL] [Abstract][Full Text] [Related]
29. Effect of preparative variables on small interfering RNA loaded Poly(D,L-lactide-co-glycolide)-chitosan submicron particles prepared by emulsification diffusion method.
Katas H; Chen S; Osamuyimen AA; Cevher E; Oya Alpar H
J Microencapsul; 2008 Dec; 25(8):541-8. PubMed ID: 18465303
[TBL] [Abstract][Full Text] [Related]
30. The manufacturing techniques of various drug loaded biodegradable poly(lactide-co-glycolide) (PLGA) devices.
Jain RA
Biomaterials; 2000 Dec; 21(23):2475-90. PubMed ID: 11055295
[TBL] [Abstract][Full Text] [Related]
31. Colonic gene silencing using siRNA-loaded calcium phosphate/PLGA nanoparticles ameliorates intestinal inflammation in vivo.
Frede A; Neuhaus B; Klopfleisch R; Walker C; Buer J; Müller W; Epple M; Westendorf AM
J Control Release; 2016 Jan; 222():86-96. PubMed ID: 26699423
[TBL] [Abstract][Full Text] [Related]
32. Poly(D,L-lactide-co-glycolide) nanoparticles encapsulated fluorescent isothiocyanate and paclitaxol: preparation, release kinetics and anticancer effect.
Yang H; Li K; Liu Y; Liu Z; Miyoshi H
J Nanosci Nanotechnol; 2009 Jan; 9(1):282-7. PubMed ID: 19441308
[TBL] [Abstract][Full Text] [Related]
33. Co-delivery of SOX9 genes and anti-Cbfa-1 siRNA coated onto PLGA nanoparticles for chondrogenesis of human MSCs.
Jeon SY; Park JS; Yang HN; Woo DG; Park KH
Biomaterials; 2012 Jun; 33(17):4413-23. PubMed ID: 22425025
[TBL] [Abstract][Full Text] [Related]
34. Lipidoid-polymer hybrid nanoparticles loaded with TNF siRNA suppress inflammation after intra-articular administration in a murine experimental arthritis model.
Jansen MAA; Klausen LH; Thanki K; Lyngsø J; Skov Pedersen J; Franzyk H; Nielsen HM; van Eden W; Dong M; Broere F; Foged C; Zeng X
Eur J Pharm Biopharm; 2019 Sep; 142():38-48. PubMed ID: 31199978
[TBL] [Abstract][Full Text] [Related]
35. Controlled release of anti-inflammatory siRNA from biodegradable polymeric microparticles intended for intra-articular delivery to the temporomandibular joint.
Mountziaris PM; Sing DC; Chew SA; Tzouanas SN; Lehman ED; Kasper FK; Mikos AG
Pharm Res; 2011 Jun; 28(6):1370-84. PubMed ID: 21184147
[TBL] [Abstract][Full Text] [Related]
36. Nanoformulation of siRNA silencing Bcl-2 gene and its implication in cancer therapy.
Jagani HV; Josyula VR; Hariharapura RC; Palanimuthu VR; Gang SS
Arzneimittelforschung; 2011; 61(10):577-86. PubMed ID: 22164966
[TBL] [Abstract][Full Text] [Related]
37. PLGA-based nanoparticles as cancer drug delivery systems.
Sadat Tabatabaei Mirakabad F; Nejati-Koshki K; Akbarzadeh A; Yamchi MR; Milani M; Zarghami N; Zeighamian V; Rahimzadeh A; Alimohammadi S; Hanifehpour Y; Joo SW
Asian Pac J Cancer Prev; 2014; 15(2):517-35. PubMed ID: 24568455
[TBL] [Abstract][Full Text] [Related]
38. siRNA-chitosan complexes in poly(lactic-co-glycolic acid) nanoparticles for the silencing of aquaporin-1 in cancer cells.
Stigliano C; Aryal S; de Tullio MD; Nicchia GP; Pascazio G; Svelto M; Decuzzi P
Mol Pharm; 2013 Aug; 10(8):3186-94. PubMed ID: 23789777
[TBL] [Abstract][Full Text] [Related]
39. Prostate-targeted biodegradable nanoparticles loaded with androgen receptor silencing constructs eradicate xenograft tumors in mice.
Yang J; Xie SX; Huang Y; Ling M; Liu J; Ran Y; Wang Y; Thrasher JB; Berkland C; Li B
Nanomedicine (Lond); 2012 Sep; 7(9):1297-309. PubMed ID: 22583574
[TBL] [Abstract][Full Text] [Related]
40. Magnetic core-shell nanoparticles for drug delivery by nebulization.
Verma NK; Crosbie-Staunton K; Satti A; Gallagher S; Ryan KB; Doody T; McAtamney C; MacLoughlin R; Galvin P; Burke CS; Volkov Y; Gun'ko YK
J Nanobiotechnology; 2013 Jan; 11():1. PubMed ID: 23343139
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]